Literature DB >> 10704146

Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.

E Waszczykowska1, E Robak, A Wozniacka, J Narbutt, J D Torzecka, A Sysa-Jedrzejowska.   

Abstract

We estimated the serum levels of IL-6, TNF-alpha and IL-10, and generation of superoxide radicals, as well as their mutual dependence, in 63 SLE patients at various stages of disease activity. Our results indicate a statistically significant increase of the serum levels studied, and an increase of superoxide anion generation by granulocytes, in correlation with SLE activity. These results indicate that oxygen metabolism and the examined cytokines play an important role in pathogenesis of SLE. The assessment of these parameters can be useful in the estimation of disease activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704146      PMCID: PMC1781789          DOI: 10.1080/09629359990586

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  29 in total

Review 1.  Cytokine abnormalities in human lupus.

Authors:  M Linker-Israeli
Journal:  Clin Immunol Immunopathol       Date:  1992-04

Review 2.  Cytokines: coordinators of immune and inflammatory responses.

Authors:  K I Arai; F Lee; A Miyajima; S Miyatake; N Arai; T Yokota
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

3.  Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

Authors:  M Linker-Israeli; R J Deans; D J Wallace; J Prehn; T Ozeri-Chen; J R Klinenberg
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

4.  [Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].

Authors:  C Witt; K Neuhaus; K Winsel; A Brenke; F Hiepe; H D Volk
Journal:  Z Erkr Atmungsorgane       Date:  1991

5.  Scavengers of free radical oxygen affect the generation of low molecular weight DNA in stimulated lymphocytes from patients with systemic lupus erythematosus.

Authors:  P J Benke; H Levcovitz; J Paupe; E Tozman
Journal:  Metabolism       Date:  1990-12       Impact factor: 8.694

Review 6.  Reactive oxygen species and airway inflammation.

Authors:  P J Barnes
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

7.  Reactive oxygen species modified DNA fragments of varying size are the preferred antigen for human anti-DNA autoantibodies.

Authors:  J Ara; R Ali
Journal:  Immunol Lett       Date:  1992-12       Impact factor: 3.685

8.  Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).

Authors:  K Mitamura; H Kang; Y Tomita; H Hashimoto; S Sawada; T Horie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

9.  Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.

Authors:  M al-Janadi; S al-Balla; A al-Dalaan; S Raziuddin
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

10.  Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells.

Authors:  H Ishida; R Hastings; J Kearney; M Howard
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  11 in total

1.  Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.

Authors:  Nadine Glesse; Paula Rohr; Odirlei André Monticielo; Tássia Flores Rech; João Carlos Tavares Brenol; Ricardo Machado Xavier; Kátia Kvitko; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.

Authors:  Lisong Yang; Di Feng; Xiaohui Bi; Rivka C Stone; Betsy J Barnes
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

3.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

4.  Superoxide release in juvenile systemic lupus erythematosus.

Authors:  Roberto Marini; Antonio Condino-Neto; Simone Appenzeller; André M Morcillo; Lilian T L Costallat
Journal:  Rheumatol Int       Date:  2011-04-03       Impact factor: 2.631

5.  Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia.

Authors:  B J M Ripley; B Goncalves; D A Isenberg; D S Latchman; A Rahman
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

6.  Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Michaele B Manigrasso; Samira C Grifoni; Babbette B LaMarca; Christine Maric; Lorraine C Racusen; Porter H Glover; Allison V Jones; Heather A Drummond; Michael J Ryan
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

7.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

Review 8.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Authors:  Hui Peng; Wei Wang; Mo Zhou; Rui Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-05-25       Impact factor: 2.980

Review 9.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

10.  Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis.

Authors:  Sawsan J Hayat; Sukhbir S Uppal; M R Narayanan Nampoory; Kaivilayil V Johny; Ramkumar Gupta; Mohammed Al-Oun
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.